Literature DB >> 18227480

Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed?

Philip D Hardt1, Mathias D Brendel, Hans U Kloer, Reinhard G Bretzel.   

Abstract

Exocrine pancreatic insufficiency is frequently associated with diabetes, with high prevalence in both insulin-dependent or insulin-independent patients. Exocrine pancreatic failure has often been perceived as a complication of diabetes. In contrast, recent clinical observations lead to the notion that nonendocrine pancreatic disease is a critical factor for development rather than a sequel to diabetes. The incidence of diabetes caused by exocrine pancreatic disease appears to be underestimated and may comprise 8% or more of the general diabetic patient population. Nonendocrine pancreas disease can cause diabetes by multiple mechanisms. Genetic defects have been characterized, resulting in a syndrome of both exocrine and endocrine failure. Regulation of beta-cell mass and physiological incretin secretion are directly dependent on normal exocrine function. Algorithms for diagnosis and therapy of diabetes should therefore address both endocrine and exocrine pancreatic function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227480     DOI: 10.2337/dc08-s244

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  52 in total

Review 1.  Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.

Authors:  Melvin R Hayden; Kamlesh Patel; Javad Habibi; Deepa Gupta; Seema S Tekwani; Adam Whaley-Connell; James R Sowers
Journal:  J Cardiometab Syndr       Date:  2008

2.  Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012.

Authors:  Michael R Rickels; Melena Bellin; Frederico G S Toledo; R Paul Robertson; Dana K Andersen; Suresh T Chari; Randall Brand; Luca Frulloni; Michelle A Anderson; David C Whitcomb
Journal:  Pancreatology       Date:  2013-05-17       Impact factor: 3.996

Review 3.  [Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Sandra Zlamal-Fortunat; Heinz F Hammer
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

Review 4.  Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.

Authors:  J Enrique Domínguez-Muñoz; Philip D Hardt; Markus M Lerch; Matthias J Löhr
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

5.  Higher mortality of patients on haemodialysis with pancreatic diabetes compared to type 2-diabetes.

Authors:  Gert Bodlaj; Georg Biesenbach
Journal:  Diabetol Metab Syndr       Date:  2012-03-23       Impact factor: 3.320

Review 6.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

7.  Genetics and treatment options for recurrent acute and chronic pancreatitis.

Authors:  Celeste A Shelton; David C Whitcomb
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

8.  Pharmacological attenuation of chronic alcoholic pancreatitis induced hypersensitivity in rats.

Authors:  Sabrina L McIlwrath; Karin N Westlund
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

9.  Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy.

Authors:  Sachiyo Shirakawa; Ippei Matsumoto; Hirochika Toyama; Makoto Shinzeki; Tetsuo Ajiki; Takumi Fukumoto; Yonson Ku
Journal:  J Gastrointest Surg       Date:  2012-09-28       Impact factor: 3.452

10.  [Position paper: Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Werner Fortunat; Heinz Hammer
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.